Inhibrx, Inc. — Form D
Inhibrx, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-31. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-31
- Form: D
- Accession: 0001739614-23-000064
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200.0M
- Amount sold: $200.0M
- Investors: 5
- Date of first sale: 2023-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-491160
Issuer
- Name: Inhibrx, Inc.
- CIK: 0001739614
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2017
- Address: 11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CA, 92037
- Phone: (858) 795-4220
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Douglas Forsyth | Director | La Jolla, CA |
| Jon Kayyem | Director | La Jolla, CA |
| Mark Lappe | Director | La Jolla, CA |
| Kimberly Manhard | Director | La Jolla, CA |
| Kristiina Vuori | Director | La Jolla, CA |
| Kelly Deck | Executive Officer | La Jolla, CA |
| Brendan Eckelman | Executive Officer | La Jolla, CA |
| Mark Lappe | Executive Officer | La Jolla, CA |
| Judith Li | Director | San Diego, CA |
| Brendan Eckelman | Director | La Jolla, CA |
| Doug Forsyth | Director | La Jolla, CA |
| Kelly Faiz Deck | Executive Officer | La Jolla, CA |
| Judith Faiz Li | Director | La Jolla, CA |
| Doug Faiz Forsyth | Director | La Jolla, CA |
| Margery Faiz Fischbein | Director | La Jolla, CA |
| Jon Faiz Kayyem | Director | La Jolla, CA |
Other filings by this issuer (4)
More